Unusual Case of Systemic Lupus Erythematosus (SLE) With Middle-Age Onset and Atypical Multisystem Involvement Middle-Age Onset SLE With Multisystem Involvement
Main Article Content
Abstract
Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder predominantly affecting young females, with middle-age onset in males being a rare occurrence. Late-onset SLE can present with atypical multisystem involvement, complicating diagnosis and management.
Objective: To report an unusual case of SLE in a middle-aged male with multisystem complications, including lupus nephritis and pulmonary hypertension.
Methods: A 52-year-old male with dyspnea, chest pain, and lower extremity edema underwent comprehensive clinical evaluation. Laboratory tests included complete blood count, renal function tests, 24-hour urinary protein, and serological markers (ANA, anti-dsDNA). Imaging studies included echocardiography and high-resolution CT. Renal biopsy confirmed Class IV lupus nephritis. The patient received high-dose corticosteroids, hydroxychloroquine, and mycophenolate mofetil, with supportive management for pulmonary hypertension.
Results: The patient’s 24-hour proteinuria reduced from 4.2 g/day to 1.2 g/day. Pulmonary artery pressure improved from 35 mmHg to 30 mmHg after four weeks. Pleural effusions resolved completely, and renal function stabilized (creatinine from 1.9 mg/dL to 1.3 mg/dL).
Conclusion: This rare presentation of late-onset SLE in a male underscore the need for comprehensive evaluation and early intervention to prevent severe complications.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Sontheimer RD. Lupus Erythematosus and the Skin. Journal of Investigative Dermatology. 2009;129(2):276-287.
Friedman A, Putterman C. Lupus Nephritis: A Review. American Journal of Kidney Diseases. 2017;69(5):688-694.
Moroni G, Raffiotta F, Ponticelli C. Management of Lupus Nephritis. Nature Reviews Nephrology. 2018;14(6):381-392.
Zhang Y, Zhang L, Wang Y, Zhang L. Lupus Pneumonitis: Clinical Features and Outcomes. BMC Pulmonary Medicine. 2017;17(1):57.
Drenkard C, Villa AR, Alarcón GS. Prevalence of Systemic Lupus Erythematosus in the United States: A Population-Based Study. Arthritis & Rheumatology. 2014;66(12):3545-3551.
Peterson AL, Ward MM, Fuentes AE, Malignancy P. The Impact of Lupus Nephritis on Outcomes in Systemic Lupus Erythematosus. Lupus Science & Medicine. 2015;2(1).
Hoffman R, Wilkinson M, Muller R. Pulmonary Hypertension in Systemic Lupus Erythematosus. Lupus. 2019;28(2):156-162.
McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. Treatment of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 2005;46(1):117-124.